NCT05193474

Brief Summary

The goal of this clinical research study is to study the cardiopulmonary resuscitation (CPR) preferences of patients receiving peritoneal dialysis and how these preferences are associated with their responses to questions about aspects of end-of-life care. This prospective cohort clinical trial aims to provide evidence on the preferences of end of life care in patients receiving peritoneal dialysis, thereby provide optimal care according to patients' preferences and choices through effective communication and clear goals of care.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 18, 2022

Completed
14 days until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

January 28, 2022

Status Verified

August 1, 2021

Enrollment Period

Same day

First QC Date

December 8, 2021

Last Update Submit

January 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the preferences of end of life care in patients receiving peritoneal dialysis

    Participants were asked to respond to the questions(POLST questionnaire) associated to life-sustaining treatment preference including CPR preference and other treatment preferences, and life values,

    up to 24 weeks

Secondary Outcomes (4)

  • compare the quality of life after receiving timely integrated palliative care to the other group

    3 moths,6 months and 12months after receiving timely integrated palliative care

  • compare the quality of death after receiving timely integrated palliative care to the other group

    3 moths,6 months and 12months after receiving timely integrated palliative care

  • compare the symptoms burden after receiving timely integrated palliative care to the other group

    3 moths,6 months and 12months after receiving timely integrated palliative care

  • compare the ICU admission frequency after receiving timely integrated palliative care to the other group

    3 moths,6 months and 12months after receiving timely integrated palliative care

Study Arms (2)

Refuse to integrate palliative care into usual care.

NO INTERVENTION

Usual ESRD care team

Agree to integrate palliative care into usual care.

EXPERIMENTAL

Usual ESRD care + combined palliative care team

Behavioral: integrated palliative care

Interventions

shared decision making with patient, and timely integrated palliative care according to patient's preference

Agree to integrate palliative care into usual care.

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \[Patients\] Diagnosis of ESRD
  • \[Patients\] Under treatment of peritoneal dialysis
  • \[Patients\] Age 20 years or older
  • \[Caregivers\] Age20 years or older

You may not qualify if:

  • \[Patients\] unable to understand or fill in the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chun-Fu Lai, M.d.

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pei-Ni Chuang, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2021

First Posted

January 18, 2022

Study Start

February 1, 2022

Primary Completion

February 1, 2022

Study Completion

August 31, 2023

Last Updated

January 28, 2022

Record last verified: 2021-08